Short description
Cardium Therapeutics is a regenerative medicine biotechnology company.
Description
Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to partnering, commercialization and other economic monetizations.
Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing and cardiovascular indications, and the To Go Brands nutraceutical supplement business.
Last funding
Cannot Access
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2003
Exited on
July 1, 2013
Went public on
July 1, 2013
Stock symbol
CRXM
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Founders
Chris Reinhard